Barclays raises Boston Scientific (NYSE:BSX) price target from $56 to $59

By / / Barclays, Boston Scientific

Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $56 to $59.

Scroll to Top